71 related articles for article (PubMed ID: 10560410)
1. [Intrabiliary administration of doxorubicin for pancreaticobiliary cancer].
Nagahama T; Maruyama M; Nakamura N; Irie T; Yoshida T; Kure N; Ebuchi M
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1849-52. PubMed ID: 10560410
[TBL] [Abstract][Full Text] [Related]
2. [Intrabiliary tract administration of adriamycin in bile duct cancer].
Mizuno I; Tanada F; Iwai A; Kato F; Yura J
Gan To Kagaku Ryoho; 1982 Apr; 9(4):681-7. PubMed ID: 7184421
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial.
Takada T; Nimura Y; Katoh H; Nagakawa T; Nakayama T; Matsushiro T; Amano H; Wada K
Hepatogastroenterology; 1998; 45(24):2020-6. PubMed ID: 9951857
[TBL] [Abstract][Full Text] [Related]
4. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.
Takada T; Amano H; Yasuda H; Nimura Y; Matsushiro T; Kato H; Nagakawa T; Nakayama T;
Cancer; 2002 Oct; 95(8):1685-95. PubMed ID: 12365016
[TBL] [Abstract][Full Text] [Related]
5. [A case of intrahepatic bile duct cancer responding to 5-fluorouracil, adriamycin and mitomycin C chemotherapy].
Uchiyama K; Takada T; Yasuda H; Hasegawa H; Tsuchiya S; Misu Y; Saitoh Y; Shikata J; Kozakai M
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1987-90. PubMed ID: 3132897
[TBL] [Abstract][Full Text] [Related]
6. [Intra-arterial infusion chemotherapy with side-hole catheter for primary and metastatic liver, bile duct, and pancreas cancers].
Tezuka T; Shinohara K; Miura T; Takagi S; Murata M; Seki M
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1572-5. PubMed ID: 1530311
[TBL] [Abstract][Full Text] [Related]
7. [Serum uptake of doxorubicin intravesically administered soon after transurethral resection of bladder carcinoma].
Nagakura K; Takao M; Odajima K; Ieda K; Fujioka T; Hayakawa M; Murai M; Nakamura H
Hinyokika Kiyo; 1989 Sep; 35(9):1509-12. PubMed ID: 2816617
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
9. The effects of bile duct obstruction on the biliary secretion of ciprofloxacin in piglets.
Chen CY; Shiesh SC; Wu MC; Lin XZ
Am J Gastroenterol; 1999 Sep; 94(9):2408-11. PubMed ID: 10484000
[TBL] [Abstract][Full Text] [Related]
10. Concomitant chemoradiation treatment in the management of patients with extrahepatic biliary tract recurrence of gastric carcinoma.
Lo SS; Wu CW; Chi KH; Tseng HS; Shen KH; Hsieh MC; Lui WY
Cancer; 2000 Jul; 89(1):29-34. PubMed ID: 10896997
[TBL] [Abstract][Full Text] [Related]
11. Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
Furuse J; Okusaka T; Funakoshi A; Yamao K; Nagase M; Ishii H; Nakachi K; Ueno H; Ikeda M; Morizane C; Horikawa Y; Mizuno N
Jpn J Clin Oncol; 2006 Sep; 36(9):552-6. PubMed ID: 16887837
[TBL] [Abstract][Full Text] [Related]
12. [A case of liver metastatic recurrence of bile duct cancer completely responding to single drug, UFT, chemotherapy].
Matsuyama S; Kitahara K; Hirano T; Magata S; Shimonishi T; Mori M; Miyazaki K
Gan To Kagaku Ryoho; 2004 Jan; 31(1):113-5. PubMed ID: 14750334
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in pancreaticobiliary maljunction.
Matsumoto Y; Fujii H; Itakura J; Matsuda M; Nobukawa B; Suda K
J Hepatobiliary Pancreat Surg; 2002; 9(1):45-54. PubMed ID: 12021897
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy in cancer of the liver, pancreas and bile ducts. Consensus statement of a workshop at The Swedish Society for Upper Abdominal Surgery sponsored by the Swedish Cancer Society.
Ihse I
Eur J Surg; 1998 Jan; 164(1):3-4. PubMed ID: 9537701
[No Abstract] [Full Text] [Related]
15. [Two cases of advanced extrahepatic bile duct cancer successfully treated by S-1 monotherapy].
Ueno H; Ikeda M
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1311-4. PubMed ID: 17687221
[TBL] [Abstract][Full Text] [Related]
16. Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study.
Theodors A; Bukowski RM; Hewlett JS; Livingston RB; Weick JK
Am J Clin Oncol; 1982 Oct; 5(5):555-8. PubMed ID: 6217742
[TBL] [Abstract][Full Text] [Related]
17. [Intraductal chemotherapy of bile duct cancer with 5-fluorouracil].
Schmeck HJ; Bartels E; Viets CH; Arnold W
Klin Wochenschr; 1986 Aug; 64(15):713-6. PubMed ID: 2429017
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of single-day GemOx regimen in patients with pancreatobiliary cancer: a single institution experience.
Li J; Merl M; Lee MX; Kaley K; Saif MW
Expert Opin Drug Saf; 2010 Mar; 9(2):207-13. PubMed ID: 20095915
[TBL] [Abstract][Full Text] [Related]
19. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model.
Shiraga E; Barichello JM; Ishida T; Kiwada H
Int J Pharm; 2008 Apr; 353(1-2):65-73. PubMed ID: 18155369
[TBL] [Abstract][Full Text] [Related]
20. Double cancer of gallbladder and bile duct associated with anomalous junction of the pancreaticobiliary ductal system.
Takayashiki T; Miyazaki M; Kato A; Ito H; Nakagawa K; Ambiru S; Shimizu H; Furuya S; Nakajima N
Hepatogastroenterology; 2002; 49(43):109-12. PubMed ID: 11941931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
